Nuwellis (NUWE) Cash & Equivalents (2011 - 2026)
Nuwellis' (NUWE) quarterly Cash & Equivalents came in at $3.9 million in Q2 2026, down 11.87% on a YoY basis from $4.4 million in Q2 2025, and up 88.29% quarter-over-quarter from $2.1 million in Q1 2026.
Analysis
Nuwellis (NUWE) Cash & Equivalents (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Cash & Equivalents for 16 consecutive years, with $3.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash & Equivalents fell 11.87% year-over-year to $3.9 million; the trailing twelve-month figure through Jun 2026 stood at $3.9 million (down 11.87% YoY), and the FY2025 full-year result was $1.1 million, down 78.7% from the prior year.
- Cash & Equivalents climbed to $3.9 million in Q2 2026 per NUWE's latest filing, from $2.1 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $19.3 million in Q1 2022 and bottomed at $1.0 million in Q2 2024.
- Historically, Cash & Equivalents has averaged $6.7 million across 5 years, with a median of $4.2 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Cash & Equivalents sank 88.5% in 2024, then surged 335.0% in 2025.
- Over 5 years, Cash & Equivalents stood at $17.7 million in 2022, then slumped by 78.58% to $3.8 million in 2023, then jumped by 34.08% to $5.1 million in 2024, then slumped by 78.7% to $1.1 million in 2025, then soared by 261.47% to $3.9 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $3.9 million, $2.1 million, and $1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 2.76 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.69 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.39 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 2.91 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 1.36 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 1.11 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 3.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.92 Mn |
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | 4.45 Mn |
| Mar 31, 2025 | 2.56 Mn |
| Dec 31, 2024 | 5.10 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 3.80 Mn |
| Sep 30, 2023 | 4.93 Mn |
| Jun 30, 2023 | 8.90 Mn |
| Mar 31, 2023 | 11.52 Mn |
| Dec 31, 2022 | 17.74 Mn |
| Sep 30, 2022 | 12.05 Mn |
| Jun 30, 2022 | 15.35 Mn |
| Mar 31, 2022 | 19.30 Mn |
| Dec 31, 2021 | 8.74 Mn |
| Sep 30, 2021 | 28.43 Mn |